MEP38208A - COMPOSITION CONTAINING AN ANDROGENOUS 11beta-HALOGEN STEROID AND A PROGESTATIONAL HORMONE, AND MALE CONTRACEPTIVE BASED ON SAID COMPOSITION - Google Patents

COMPOSITION CONTAINING AN ANDROGENOUS 11beta-HALOGEN STEROID AND A PROGESTATIONAL HORMONE, AND MALE CONTRACEPTIVE BASED ON SAID COMPOSITION

Info

Publication number
MEP38208A
MEP38208A MEP-382/08A MEP38208A MEP38208A ME P38208 A MEP38208 A ME P38208A ME P38208 A MEP38208 A ME P38208A ME P38208 A MEP38208 A ME P38208A
Authority
ME
Montenegro
Prior art keywords
composition
androgenous
11beta
male contraceptive
composition containing
Prior art date
Application number
MEP-382/08A
Other languages
Bosnian (bs)
Inventor
Reinhard Nubbemeyer
Ursula-Friederike Habenicht
Rolf Bohlmann
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Priority claimed from PCT/EP2003/008192 external-priority patent/WO2004011008A1/en
Publication of MEP38208A publication Critical patent/MEP38208A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Predloženi pronalazak opisuje novi hemiski sastav koji sadrži jedfan androgen 11β-halogensteroid i gestagen formule I, jedan farmaceutski sastav koji sadržiovaj hemiski sastav kao i muški kontraceptiv na bazi ovih farmaceutskih sastava.The present invention discloses a novel chemical composition comprising an androgen 11β-halogen steroid and a gestagen of formula I, a pharmaceutical composition comprising a chemical composition as well as a male contraceptive based on these pharmaceutical compositions.

MEP-382/08A 2002-07-25 2003-07-25 COMPOSITION CONTAINING AN ANDROGENOUS 11beta-HALOGEN STEROID AND A PROGESTATIONAL HORMONE, AND MALE CONTRACEPTIVE BASED ON SAID COMPOSITION MEP38208A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10234525A DE10234525A1 (en) 2002-07-25 2002-07-25 New compositions, useful as male contraceptives, comprise synergistic active agent combination of androgenic 11beta-halo-steroid and gestagenic 14 alpha, 17alpha-ethylene-estratrienone derivative
US44940003P 2003-02-25 2003-02-25
PCT/EP2003/008192 WO2004011008A1 (en) 2002-07-25 2003-07-25 COMPOSITION CONTAINING AN ANDROGENOUS 11β-HALOGEN STEROID AND A PROGESTATIONAL HORMONE, AND MALE CONTRACEPTIVE BASED ON SAID COMPOSITION

Publications (1)

Publication Number Publication Date
MEP38208A true MEP38208A (en) 2011-02-10

Family

ID=30010499

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-382/08A MEP38208A (en) 2002-07-25 2003-07-25 COMPOSITION CONTAINING AN ANDROGENOUS 11beta-HALOGEN STEROID AND A PROGESTATIONAL HORMONE, AND MALE CONTRACEPTIVE BASED ON SAID COMPOSITION

Country Status (9)

Country Link
AR (1) AR040691A1 (en)
CO (1) CO5690601A2 (en)
DE (1) DE10234525A1 (en)
EA (1) EA007601B1 (en)
ME (1) MEP38208A (en)
NO (1) NO20050995L (en)
RS (1) RS50907B (en)
UA (1) UA78834C2 (en)
ZA (1) ZA200501653B (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3714965A1 (en) * 1987-04-30 1988-11-10 Schering Ag 3-METHYLENE-4-ANDROSTEN-17-ONE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
DE19650352A1 (en) * 1996-12-04 1998-07-30 Jenapharm Gmbh New male oral contraceptive composition
US5952319A (en) * 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
DE19848303A1 (en) * 1998-10-14 2000-04-20 Schering Ag Stable combination of 14,17-over-bridged steroid gestagen and cyclodextrin compound, useful for treating climacteric disorders or for contraception
EE200200454A (en) * 2000-02-15 2003-12-15 Schering Aktiengesellschaft Male contraceptive containing norethisterone
EP1216699A1 (en) * 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermal system comprising a highly potent progestin
DE10104327A1 (en) * 2001-01-24 2002-07-25 Schering Ag New 11beta-halo-testosterone derivatives useful in male hormone replacement therapy and in male fertility control

Also Published As

Publication number Publication date
RS20050049A (en) 2007-09-21
NO20050995L (en) 2005-04-25
RS50907B (en) 2010-08-31
CO5690601A2 (en) 2006-10-31
DE10234525A1 (en) 2004-02-05
EA200500222A1 (en) 2005-08-25
ZA200501653B (en) 2007-11-28
EA007601B1 (en) 2006-12-29
UA78834C2 (en) 2007-04-25
AR040691A1 (en) 2005-04-13

Similar Documents

Publication Publication Date Title
ECSP055629A (en) COMPOSITION CONTAINING AN ANDROGEN 11ß-HALOGENATED STEROID AND A GESTAGEN AS WELL AS A MALE CONTRACEPTIVE ON THE BASIS OF THESE COMPOSITIONS
EE05282B1 (en) ™ strogen-ts compositions of clodextrin complexes
EA200901393A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENES AND / OR ESTROGENS AND 5 METHYL- (6S) -TETRAHYDROPHOLATE
TW200716137A (en) Tanaproget compositions containing ethinyl estradiol
RS90504A (en) C-17 spirolactonization and 6,7 oxidation of steroids
TR200401052T4 (en) New compounds
MEP38208A (en) COMPOSITION CONTAINING AN ANDROGENOUS 11beta-HALOGEN STEROID AND A PROGESTATIONAL HORMONE, AND MALE CONTRACEPTIVE BASED ON SAID COMPOSITION
EP1857111A3 (en) Composition comprising a combination of an aromatase inhibitor, a progestin and an estrogen, and its use for the treatment of endometriosis
ATE317700T1 (en) USE OF (11BETA, 17BETA)-11-(1,3-BENZODIOXOL-5-YL)-17-HYDROXY-17-(1-PROPINYL)-ESTRA-4,9-DIEN-3-ONE FOR THE TREATMENT OF SEVERE DEPRESSION
DE602004018921D1 (en) D DIENOGEST
HUP0301592A2 (en) 16alpha-methyl or ethyl substituted estrogens and pharmaceutical compositions thereof
DK1444247T3 (en) tibolone formulations
ATE328595T1 (en) CARVEDILOL POLYMORPHOUS
AU2002339199A8 (en) Solvates of 3.beta., 28-diacetoxy-18-oxo-19, 20, 21, 29, 30-pentanorlupan-22-oic acid, processes for their preparation and pharmaceutical compositions thereof
TW200603812A (en) D-homo-17-chlor-16(17)-ene steroids